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ABSTRACT
Genetic Differentiation of oral and oropharyngeal carcinoma based on Human Papillomavirus
Status and Race
By
Aastha Vashist
December 7th, 2016

INTRODUCTION: Head and neck cancer is one of the most common malignancy in the world.
While it has been associated with several factors like alcohol consumption and smoking, there is
approximately 25% of head and neck cancer that can be attributed to Human Papillomavirus
(HPV) especially HPV 16. HPV associated cancer has been associated with a better prognosis as
compared to HPV negative cancers. It has also been shown in previous studies that HPVnegative African Americans have a higher mortality rate as compared to HPV associated cancers
in European Americans and HPV-negative European Americans patients. The three states of
HPV associated cancers have been compared, which included HPV active, HPV inactive and
HPV negative.
AIM: The study aims include: 1) Compare the differences in the gene expression profiles of
HPV negative HNSCC in AA from EA patients, and determine the differences in their biological
make up. 2) Explore and compare the genetic expression profiles of HPV-active, HPV-inactive
and HPV-negative head and neck cancer patients.
METHODS: A secondary data analysis was conducted on 36 oropharyngeal cancer tissues
samples with different HPV status (HPV-active, HPV-inactive and HPV- negative). ANOVA
was conducted in R to compare all the three groups from each other and identify the genes that
were differentially expressed. Bayes Moderated paired t-test was used to compare two groups of
HPV-negative European Americans with HPV-negative African Americans.
RESULTS: Our analysis revealed that the genes that were differentially expressed in HPVactive and HPV-negative analysis were different from HPV-active and HPV-inactive analysis.
Our analysis also identified genes that were differentially expressed in African Americans as
compared to European Americans.
DISCUSSION: This study provides the genetic expression profiles in different groups (European
Americans and African Americans) based on different HPV stages. Despite the small sample size
of our data, we were able to identify the genes that were differentially expressed amongst
different conditions in patients who had oropharyngeal carcinoma. We were also able to identify
the genes involved in HPV-negative oral cancer comparing the African Americans to the
European Americans.
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Introduction
Head and neck cancer (HNC) is the fifth most common malignancy worldwide with an annual
mortality rate of 200,000. Approximately 90% of HNC can be classified as head and neck
squamous cell carcinomas (HNSCC), of which approximately 75% are attributed to alcohol and
tobacco consumption and 25% are associated with human papillomavirus (HPV), predominantly
HPV16 (Tomar et al., 2016). It has been shown in previous studies that HPV associated with Oro
Pharyngeal Carcinoma have a better prognosis and respond better to therapy as compared to
HPV- negative tumors (Weinberger et al., 2006). It can be seen from the differences in risk
factors, age of presentation, clinical behavior and gene expression profiles that HPV-positive and
HPV-negative tumors develop via different molecular mechanisms and are biologically distinct
(Deng et al., 2013). African Americans (AA) males have shown to have higher incidence of
HNC than any other racial/gender group, and have a three-times mortality rate than that observed
in European Americans (EA) males (Cole, Polfus, & Peters, 2012a). Previous studies have
indicated that AA tend to present with more HPV-negative OPC and have worse prognosis as
compared to both HPV-positive and HPV-negative HNSCC in EA patients (Zandberg et al.,
2016). This study aims to compare the differences in the gene expression profiles of HPV
negative HNSCC in AA from EA patients, and determine the differences in their biological make
up. We also aim at exploring and comparing the genetic expression profiles of HPV-active,
HPV-inactive and HPV-negative head and neck cancer patients
Literature Review:
Head and neck cancer (HNC), which is defined as the cancer of the oral cavity, pharynx,
larynx, paranasal sinuses and nasal cavity and the salivary glands, is the ninth most common
cancer in the USA and 14th most common cause of death (Daraei & Moore, 2015). Even though
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the incidence of head and neck cancer has plateaued now, its mortality and morbidity continue to
remain high (Curado & Boyle, 2013). The incidence, mortality, and the relative survival rates of
HNC vary with respect to sex and race. The incidence and mortality rates are more than twice as
high in men as in women, and are greatest in men who are older than 50 years of age (Cole,
Polfus, & Peters, 2012b). African American men have a higher incidence and mortality rates for
HNC as compared to white men (Weinberger et al., 2010). Incidence rates for African American
and white women are almost similar, though African American women have a slightly higher
mortality rate compared to white women (Gourin & Podolsky, 2006). Both the incidence and
mortality rates depend upon the anatomic location of the tumor and vary considerably. It has
been shown that tongue and oropharynx are the anatomic sites that have the highest incidence
and mortality rates. In addition to the anatomic sites, the stage of cancer also strongly affects the
survival rate. The five-year relative survival rate for localized tumors is approximately 83%, in
comparison to regional tumors that demonstrate 54% of five-year relative survival rate and
distant tumors have a 32% five-year relative survival rates (Cole et al., 2012b).
The HPV-related oropharyngeal cancer results from the ability of the virus to infect the
discontinuous reticulated epithelium of tonsillar crypts (Andersen, Koldjær Sølling, Ovesen, &
Rusan, 2014). HPV results in anogenital and oropharyngeal cancer by transforming primary
human keratinocytes from genital or oral epithelia and also by disrupting cell-cycle regulatory
pathways (Yim & Park, 2005). The precise mechanisms due to which HPV results in malignant
transformation of the keratinocytes in the upper digestive tract epithelia are unknown. It has been
hypothesized that HPV E7 causes the overexpression of p16INK4A (Li, Nichols, Shay, & Xiong,
1994), which is considered a surrogate marker for HPV positivity/activity (Klaes et al., 2001).
However, this biomarker alone is not sufficient as a predictor of HPV positivity in different
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mucosal subsites of head and neck cancer (Wilson DD, Rahimi AS, Saylor DK, & et al, 2012).
Hence, it is important to assess viral load and viral oncogenic expression, leading in further
classification of HPV-positive oropharyngeal cancers as HPV-active and HPV-inactive (Deng et
al., 2013).
Other risk factors associated with HNC include the intensity and duration of alcohol and
tobacco consumption (Dal Maso et al., 2016). Approximately 75% of HNC cases are attributable
to alcohol and tobacco exposure, whereas 15-20% of cases consist of non-smokers and nondrinkers (Cole et al., 2012b). This shows that the etiology of HNC has other risk factors besides
alcohol and smoking.
The role of HPV, specifically HPV-16, in oropharyngeal cancer is well
established(Brawley, 2009). Recent epidemiological studies of oral HPV infection in the US
population have observed that the distribution of high-risk HPV infection is similar to the risk for
the OPC in the United States (Gillison et al., 2008). The prevalence of oral high-risk and HPV 16
infections in the United States was almost three to five fold higher among men than in women,
which is consistent with the three to five-fold relative risk for OPC among compared to
women(Gillison et al., 2008). The high prevalence of HPV-related oropharyngeal carcinoma is
determined by the ability of the virus to infect the reticular epithelium of tonsillar crypts(Tomar
et al., 2016). The tumor HPV status is considered as an important prognostic factor for HNC
based on the survival rates associated with HPV-positive versus HPV-negative HNC (Firmino et
al., 2016). Patients with HPV-positive oropharyngeal tumors have a better prognosis compared
with HPV-negative oropharyngeal patients (Firmino et al., 2016). Previous studies have
identified E6/E7-dependent inactivation of p53 and Rb tumor suppressor proteins to be the
underlying cause for the oncogenic proteins (Vlashi et al., 2016). However, studies replicating
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the clinical radiosensitivity of HPV-positive HNSCC experimentally are sparse and conflicting.
Recent reports demonstrated that HPV-positive HNSCC cell lines are more radiosensitive than
HPV-negative cell lines (Yim & Park, 2005), but a clear mechanistic link between
overexpression of HPV genes and increased radiosensitivity is still missing, thus indicating a
complex role of HPV in HNSCC RT. There have been different hypotheses about the differences
in the gene expression profiles in HPV-positive and HPV-negative HNC, which needs to be
investigated in further details.
HPV has been characterized as a risk factor for oropharyngeal cancer based on race,
lifestyle, survival outcomes in both African American and European American patients. Some
studies have reported that tumors associated with HPV are much lower in African Americans as
compared to the European Americans (Zandberg et al., 2016) whereas African Americans have a
higher incidence of head and neck cancer and a mortality rate almost 3-times than that observed
in European American men (Murdock & Gluckman, 2001). Our analysis was based of Tomar et
al. 2016 dataset and study.
Patient demographics, tumor characteristics and activity in oropharyngeal cancer from
Tomar et al. 2016
The sample was collected from the MUSC tissue bank and the inclusion criteria were that
the patients had given consent to the use of the samples for the research. The study conducted
analysis and found that there was no significant difference between African Americans and
European Americans based on clinical characteristics like alcohol consumption and smoking.
The oropharyngeal cancer samples were classified into 3 categories: whether the HPV DNA was
present and transcribed (HPV-active), HPV DNA was present and not transcribed (HPVinactive) and HPV DNA was not detected (HPV-negative).
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The data presented in the paper (Tomar et al., 2016) suggested that on average, the age of
presentation for HPV active oral and oropharyngeal carcinoma was less than the age of
presentation for HPV-negative carcinoma especially in men (mean ages in HPV active European
American men= 52 years; HPV negative = 71 years; p=0.0003). The paper also reported that the
HPV-negative cancers in African American patients presented at a younger age as compared to
the European Americans (mean ages of presentation for HPV-negative cancers: African
American men=53 years; European American men= 71 years, p- value= 0.0023). The authors
also suggested that based on the stage of cancer at presentation, there was no difference between
African American and European American patients.
The paper also depicted that despite the small sample size, the observed differences were
significant between African Americans being more likely to present with HPV-negative tumors
as compared to the European American patients. The odds of having HPV-positive tumor in
European American patients was 3.4 times in comparison to the African American patients (95%
confidence interval [CI] = 1.08–10.7; p-value= .035). The odds of presenting with an HPVactive tumor among European American patients were 5.7 times in comparison with African
American patients (95% CI = 1.15–28.6; p-value= .033).
The purpose of this study was to explore the possible genetic differences in HPV active,
inactive and negative cases and to examine the gene expression profiles in the HPV-negative
African Americans and European Americans.
Materials and Methods
Tissue Samples and Extraction of Nucleic acids
The data consisted of 36 oropharyngeal cancer tissue samples, which consisted of
samples with oral cancer, hypopharyngeal cancer and maxillary carcinoma. The sample collected
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comprised of African Americans and European American patients at MUSC (Medical University
of South Carolina), Charleston, South Carolina. The dataset was available on GEO Datasets on
NCBI. The tissue samples were total RNA and genomic DNA samples that were selected for
microarray analysis based upon the quality of frozen specimen available and the resulting RNA.
The samples were Microarray experiments and were performed using the Agilent technologies
platform. The data obtained were extracted from images with Feature extractor software version
10.7.3.1 (Agilent) where background correction was performed (Tomar et al., 2016).
Human Papillomavirus Typing and Status
Genomic DNA from oropharyngeal tissue samples was analyzed (Tomar et al., 2016) for
the presence of specific HPV by the reverse hybridization of L1 region with specific
oligonucleotides (INNO-LIPA) HPV Genotyping extra assay, a multiplex polymerase chain
reaction (PCR)- based assay based on the reverse line blot hybridization principle. The INNOLIPA assay targets a 65-bp fragment of the L1 open reading frame to detect and identify the 28
different types of HPV types, which include the 18 high risk type of HPV strains (16, 18, 26, 31,
33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82); 6 low-risk HPVs (6, 11, 40, 43, 44, 54,
and 70) and 3 other non-classified HPVs (69, 71, and 74) (van Hamont, van Ham, Bakkers,
Massuger, & Melchers, 2006). Reverse transcriptase-quantitative polymerase chain reaction (RTqPCR) assessed the type specific HPV E7 oncogene expression in order to assess the active or
inactive status of the virus in the samples (Wang et al., 2015). The primers used in order to detect
E7 were specifically designed from each individual HPV type analyzed (Tomar et al. 2015).
Approximately 51,000 genes per sample were analyzed for this study.
mRNA labelling and Microarray analysis
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The Microarray experiments were performed with the help of the Agilent technologies
platform. The total RNA samples were amplified and labelled using Agilent's Low Input Quick
Amp Labeling Kit. The mRNA contained in the total(200ng) of RNA was converted into cDNA
with the help of a poly-dT primer that also contained the T7 RNA polymerase promoter
sequence. Subsequently, T7 RNA polymerase was added to cDNA samples to amplify the
original mRNA molecules and to simultaneously incorporate cyanine-3 labeled
cricothyroidopexy into the amplification product (cRNA). In the next step, labeled cRNA
molecules were purified using Qiagen's RNeasy Mini Kit (Valencia, CA). After
spectrophotometric assessment of dye incorporation and cRNA yield, samples were stored at
−80°C until hybridization. Labeled cRNA samples (600 ng) were hybridized to SurePrint G3
Human Gene Expression 8 × 60 K v2 microarrays at 65°C for 17 hours using Agilent's Gene
Expression Hybridization Kit, in accord with the manufacturer's recommendations. After washes,
arrays were scanned using a High Resolution Agilent DNA Microarray Scanner and images
saved in TIFF format (Tomar et al., 2016).
Data Analysis
The data were log2 transformed, quantile normalized, and base line transformed using the
median of all the samples in R statistical package version 3.3.1 (Sifakis et al. 2012).
Differentially expressed genes were determined by the analysis of the data using Bayes
moderated paired t test and ANOVA in R. Benjamini & Hochberg’s False discovery rate
approach was used to calculate the adjusted p-value (Pike, 2011). Cutoff values of 0.05 and 2
were used for p value and fold change respectively. A p value of 0.05 or less was considered
significant. We conducted hierarchical cluster analysis using GeneSpring software version 14.5.
Reverse transcriptase-quantitative polymerase chain reaction

16

The iScript cDNA synthesis kit (BioRad, Hercules, CA) was used to synthesize
complementary DNA (cDNA) from the total RNA. Real-Time PCR sciTool (Integrated DNA
Technology, Coralville, IA) and Primer-Blast software (National Center for Biotechnology
Information) were used to design all other primers except TP53 and TGFB2. iCycler IQ
detection system (BioRad) with iScriptTM Sybr Green Supermix Kit (BioRad) were used to
perform RT –qPCR.
Results
Gene expression profiles of human papillomavirus-active, human papillomavirus-inactive,
and human papillomavirus-negative oropharyngeal cancer samples
The gene expression between different groups was explored. In the first step, we first
compared HPV- active samples (11 European Americans, 1 African American, all males) to
HPV- negative samples (8 European Americans, 2 females and 6 males), we discovered 400
differentially expressed genes with cut off value of 2 for log fold change (logFC). We just
included European Americans for this analysis. We compared the samples using Bayes
moderated t-test statistics in R, with the help of Benjamini & Hochberg False discovery rate
approach for calculating the adjust P-value. We found the genes with most differential
expression by using the logFC cut off value of greater than or equal to 5 and -log10(Adj. P.
Value) of greater than 2 (Figure 1A). We found 7 such highly expressed genes. We then
compared HPV-active (12 samples, all males, 11 European Americans and 1 African American)
with HPV-inactive (8 sample, 6 females and 2 males, 4 African Americans, 4 European
Americans). Our cut-off for the log fold change was 2 and we found 440 differentially expressed
genes. We found 25 genes that were highly expressed according to our criteria of both logFC cut
off of more than 5 and -log10 (Adj. P. Value) of greater than 2 (Figure 1B). The comparison of
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16 samples of HPV-negative (8 European Americans and 8 African Americans; 5 females and 11
males) with that of 8 samples of HPV- inactive depicted 48 genes with log fold change (LogFC)
cut off 2. None of the genes were highly expressed according to our criteria (Figure 1C). On
comparing the 8 samples of HPV- negative European Americans with the 8 samples of African
Americans, we found 152 genes that were differentially expressed. The number of genes
differentially expressed were a lot but none of the gene showed the high differential expression
values (Figure 1D), that is none of the genes gave values greater than 5 for logFC and -log
10(Adj. P.Value) greater than 2.
We also compared all three groups together using moderated F statistics (Table 3). We
found the genes that showed the largest F value, also showed the smallest logFC values for the
same genes in HPV active-HPV inactive comparison and HPV active-HPV negative comparison.
This showed that most of the highly differentially expressed genes were same in the two
comparison, which were not as differentially expressed in HPV inactive-HPV negative
comparison.

Figure 1
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A. Represents a volcano plot where the x- axis is the log fold change of gene expression and the yaxis is the -log 10 base of adjusted p-value between HPV active and HPV negative samples. The red
dots in the figure represent the genes that have absolute logFC less than 2 and the green dots represent
the genes that have -log 10(Adj.P.Value) of greater than 2 and absolute value of logFC value greater
than 2 but less than 5. The Blue dots represent the genes that have -log10(Adj.P.Val) greater than 2 as
well as logFC greater than or equal to 5. The genes in blue dots showed the highest expression values.
Gene names include: SMC1B: Structural maintenance of chromosome 1B; ZNF541: Zinc Finger
protein 541; LOC285084: uncharacterized gene; LOC254559: uncharacterized gene; TCAM1P:
testicular cell adhesion molecule 1; KCNS1: Potassium voltage gated channel; PAX1: Paired box1

B. Represents a volcano plot where the x- axis is the log fold change and the y- axis is the -log 10 base
of adjusted p-value between HPV active and HPV Inactive samples. The red dots in the figure
represent the genes that have -log10 (Adj.p.Value) of greater than 2 only and the green dots represent
the genes that have -log 10(Adj.P.Value) of greater than 2 and logFC value greater than 2 but less than
5. The Blue dots represent the genes that have both -log 10(Adj. P.Value) greater than 2 and logFC
greater than 5. These are the genes that are the most differentially expressed genes. Gene names
include: SMC1B: Structural maintenance of chromosome 1B; ZNF541: Zinc Finger protein 541;
LOC285084: uncharacterized gene; LOC254559: uncharacterized gene; TCAM1P: testicular cell
adhesion molecule 1; KCNS1: Potassium voltage gated channel; LOC100509121: Uncharacterized
protein; TXLNG2P: taxilin gamma 2, pseudogene; USP9Y: ubiquitin specific peptidase 9, Y-linked;
TTTY15: testis-specific transcript, Y-linked 15 (non-protein coding); RTP3: receptor (chemosensory)
transporter protein 3; DDX3Y: DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked; CLDN10:
claudin 10; KRT19P2: keratin 19 pseudogene 2; RPS4Y1: Ribosomal protein S4, Y-linked 1; RPS4Y2:
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Ribosomal protein S4, Y-linked 2; XIST: X (inactive)-specific transcript (non-protein coding); FABP4:
fatty acid binding protein 4, adipocyte; PAX1: Paired box1

C. Represents a volcano plot where the x- axis is the log fold change and the y- axis is the -log 10 base
of adjusted p-value between HPV negative and HPV Inactive samples. The black dots in the figure
represent the genes that are differentially expressed and the orange dots represent the genes that have
logFC value greater than 2 but less than 5. None of the genes had -log 10(Adj. P. Value) of greater
than 2.
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D. Represents a volcano plot where the x- axis is the log fold change and the y- axis is the -log 10 base
of adjusted p-value between HPV negative European Americans and African American samples. The
black dots in the figure represent the genes that are differentially expressed and the orange dot
represents the gene that have logFC greater than 2 but less than 5. The only pink dot represents the
gene that has logFC value greater than 5. No gene showed exceptionally high expression values.

The results depicted subtle differences in the gene expression profiles of HPV-inactive and HPVnegative samples and HPV-negative European Americans and African Americas whereas there
was more difference to be seen between HPV-active and HPV-inactive, and HPV-active and
HPV-negative samples.
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Table 1:
The table represents the comparison of the three groups and the first 50 differentially expressed genes.
ANOVA was performed to compare all the three groups (HPV-active, HPV-inactive and HPVnegative). G2…G0 represents the logFC values for HPV active (G0) with HPV-negative (G2).
G2…G1 represents the logFC values for HPV-negative with HPV-inactive (G1). G1…G0 represents
the logFC values for HPV-inactive with the HPV active samples.
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Figure 2
Unsupervised hierarchical clustering for oropharyngeal cancers comparing HPV-active, HPVinactive and HPV-negative samples.
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We also performed a hierarchical cluster analysis on our three groups: HPV-active, HPVinactive and HPV- negative. We found that our tumor samples, irrespective of the race they
belonged to cluster as we saw in our above group comparisons (Figure 2). Our HPV-inactive
tumor samples clustered with HPV-negative tumor samples and both the groups segregated from
the HPV-active group.
Discussion
The study conducted by Tomar et al. 2015, classified HPV status based on HPV DNA
detection and the expression of E7 through RT-qPCR. Hence, the tumors that tested positive for
both INNO-LiPA and E7 RT-qPCR were classified as HPV-positive, the ones that tested positive
only for INNO-LiPA were classified as HPV-inactive, whereas the ones that tested negative for
both were classified as HPV-negative tumors. Hence, this study suggests that HPV DNA is not
the sole reason for the HPV status of head and neck cancer.
Looking at the gene expression profile, we found that there were certain genes that were
differentially expressed in African Americans as compared to European Americans in HPV
negative patients. Some of these included ATP9A (which has been found to be associated with
lymphocytic leukemia). Other genes that showed differential expression included ADAM12,
MMP7, IL22RA1. MMP7 and ADAM12 have been found to be associated with protein
degradation in oral cancers (Kamatani et al., 2013), which explains the gene expression profile
difference in cancer progression between HPV-negative cancers in European Americans and
African Americans. In our moderated F statistics comparison for all the three groups we found
almost the same genes being highly differentially in HPV active-HPV inactive and HPV-active
and HPV-negative comparisons whereas the genes that were highly differentially expressed in
the two groups showed small absolute logFC value for the group HPV-inactive and HPV-
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negative (Table 3). This (along with Figure 1C that shows very few genes that are differentially
expressed), indicates towards the possibility that HPV inactive may have originated as HPV
active and then lost its dependence on HPV as the disease progressed. This explains the subtle
difference between HPV-inactive and HPV- negative cancers. This hypothesis if explored might
help in looking at the potential of HPV vaccines in the prevention of certain cancers.
Our analysis showed that most of the genes that were differentially expressed in HPVactive and HPV-inactive sample analysis were similar from the genes that were differentially
expressed in HPV-active and HPV- negative sample analysis (Figure 1A and Figure 1B). Some
of these gene were not similarly expressed in the two group comparisons. HPV active-HPVinactive comparison showed more differentially expressed genes (Figure 1B). This showed that
E7 expression through RT-qPCR resulted in HPV inactive group that lead to a different
molecular process in the causation of cancer. This depicted that HPV-inactive (with E7
expression through RT-qPCR) is a different group and the presence of E7 expression results in a
different molecular and biological process in the causation of cancer. We can also see the
difference in HPV-inactive from HPV-active by our cluster analysis, which showed that HPVinactive clustered with HPV-negative (Figure 2).
Limitations
There were certain limitations of the present study that should be noted. First, the sample
size of our study was really small. The limited power of the analysis prevented us from
comparing certain groups like African Americans HPV-active samples to HPV-negative.
Another limitation of this study was it prevented us from getting a differential expression profile
for every gene. Since, this was a secondary data, we were limited by the information provided to
us and so we couldn’t conduct RT-qPCR analysis. Hence, getting the exact value of gene
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expression in each group could not be done. Another limitation of this study was the lack of any
demographic information in the dataset. Since the data just provided the background intensity
values, it was not possible for us to see if there were any differences due to demographic
characteristics.
Future Research
The difference seen in African Americans HPV-negative samples and European
American HPV negative samples requires further investigation with larger sample size. Our
analysis showed that HPV-inactive affects different molecular and biological process need to be
further investigated by getting RT-qPCR examination of all the differentially expressed genes
and getting the exact value of expression of all the genes instead of comparison of gene values
only. It would also be useful to compare each of the HPV associated Oral squamous cell tissue
groups (European Americans and African Americans) with their own normal tissue samples.
Comparing it with normal tissue on a larger dataset can be helpful in understanding how the
process of oral cancer is progressing based on the HPV status.
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